Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$0.16 - $6.5 $46 - $1,898
-292 Reduced 0.03%
1,109,341 $354,000
Q3 2022

Nov 14, 2022

SELL
$0.31 - $7.41 $3,696 - $88,364
-11,925 Reduced 1.06%
1,109,633 $488,000
Q1 2022

May 13, 2022

BUY
$1.29 - $1.85 $33,062 - $47,415
25,630 Added 2.34%
1,121,558 $1.6 Million
Q4 2021

Feb 14, 2022

SELL
$1.19 - $2.42 $1,024 - $2,083
-861 Reduced 0.08%
1,095,928 $1.86 Million
Q3 2021

Nov 12, 2021

BUY
$1.79 - $3.27 $152,386 - $278,381
85,132 Added 8.42%
1,096,789 $2.75 Million
Q2 2021

Aug 13, 2021

BUY
$1.72 - $3.19 $1.74 Million - $3.23 Million
1,011,657 New
1,011,657 $3.15 Million

Others Institutions Holding VERO

# of Institutions
1
Shares Held
7K
Call Options Held
0
Put Options Held
0

About Venus Concept Inc.


  • Ticker VERO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 65,459,600
  • Market Cap $20.9M
  • Description
  • Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device us...
More about VERO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.